Literature DB >> 1872872

Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells.

Y Matsumura1, R Ikegawa, Y Tsukahara, M Takaoka, S Morimoto.   

Abstract

Incubation of big endothelin-1 (big ET-1, 1-39) with the membrane fraction obtained from cultured vascular smooth muscle cells (VSMCs) resulted in an increase in immunoreactive-ET (IR-ET), which was inhibited by EDTA but not by phosphoramidon, a metalloproteinase inhibitor. When the incubation was performed in the presence of N-ethylmaleimide (NEM), the generation of IR-ET was markedly augmented and this augmentation was abolished by phosphoramidon. The pH profile for IR-ET generation in the presence of NEM was apparently distinct from that observed in the absence of NEM. Reverse-phase HPLC of the incubation mixture with or without NEM revealed one major IR-ET component corresponding to the elution position of synthetic ET-1 (1-21). When the cultured VSMCs were incubated with big ET-1, a conversion to the mature ET-1 was observed. This ET-1 generation from exogenously applied big ET-1 was markedly inhibited by the addition of phosphoramidon, although the inhibitor did not influence the basal secretion of ET-1-like materials. These results suggest the presence of two types of metalloproteinases, which can generate ET-1, in VSMCs. The possibility that ET-1 functions in an autocrine manner to control the cardiovascular system warrants further attention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872872     DOI: 10.1016/0006-291x(91)90976-e

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Kinetic parameters for the generation of endothelins-1,-2 and -3 by human cathepsin E.

Authors:  P S Robinson; W E Lees; J Kay; N D Cook
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Interleukin-1 beta increases airway epithelial cell mitogenesis partly by stimulating endothelin-1 production.

Authors:  C G Murlas; A C Sharma; A Gulati; F Najmabadi
Journal:  Lung       Date:  1997       Impact factor: 2.584

3.  [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.

Authors:  Michael Zimmermann; Carla Sabine Jung; Hartmut Vatter; Andreas Raabe; Volker Seifert
Journal:  Neurosurg Rev       Date:  2002-11-19       Impact factor: 3.042

4.  Contractile activity of big endothelin-1 on the human isolated bronchus.

Authors:  C Advenier; V Lagente; Y Zhang; E Naline
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

5.  Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA.

Authors:  T D Warner; G P Budzik; T Matsumoto; J A Mitchell; U Förstermann; F Murad
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

6.  Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

7.  Big ET-1 processing into vasoactive peptides in arteries and veins.

Authors:  Stephanie W Watts; Keshari Thakali; Chuck Smark; Catherine Rondelli; Gregory D Fink
Journal:  Vascul Pharmacol       Date:  2007-09-07       Impact factor: 5.773

8.  The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes.

Authors:  S Kaw; M Hecker; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Human brain contains a metalloprotease that converts big endothelin-1 to endothelin-1 and is inhibited by phosphoramidon and EDTA.

Authors:  T D Warner; H H Schmidt; J Kuk; J A Mitchell; F Murad
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

10.  Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells.

Authors:  J C Yu; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.